Loading…

Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes

Abstract Delta-9-tetrahydrocannabinol (Δ9 -THC), the main psychoactive component of marijuana, is known to dysregulate various immune responses. Cannabinoid (CB)-1 and -2 receptors are expressed mainly on cells of the central nervous system (CNS) and the immune system. The CNS is the primary target...

Full description

Saved in:
Bibliographic Details
Published in:Brain research 2008-01, Vol.1191, p.1-11
Main Authors: Bindukumar, B, Mahajan, S.D, Reynolds, J.L, Hu, Z, Sykes, D.E, Aalinkeel, R, Schwartz, S.A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Delta-9-tetrahydrocannabinol (Δ9 -THC), the main psychoactive component of marijuana, is known to dysregulate various immune responses. Cannabinoid (CB)-1 and -2 receptors are expressed mainly on cells of the central nervous system (CNS) and the immune system. The CNS is the primary target of cannabinoids and astrocytes are known to play a role in various immune responses. Thus we undertook this investigation to determine the global molecular effects of cannabinoids on normal human astrocytes (NHA) using genomic and proteomic analyses. NHA were treated with Δ9 -THC and assayed using gene microarrays and two-dimensional (2D) difference gel electrophoresis (DIGE) coupled with mass spectrometry (MS) to elucidate their genomic and proteomic profiles respectively. Our results show that the expression of more than 20 translated protein gene products from NHA was differentially dysregulated by treatment with Δ9 -THC compared to untreated, control NHA.
ISSN:0006-8993
1872-6240
DOI:10.1016/j.brainres.2007.10.062